More information: Kim Ngan Tran et al, New composite phenotypes enhance chronic kidney disease classification and genetic associations, PLOS Genetics (2025). DOI: 10.1371/journal.pgen.1011718 ...

AstraZeneca (AZ) has announced that a wider range of chronic kidney disease (CKD) patients across England and Wales will be able to access Forxiga (dapagliflozin), following updated final draft ...

Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report) and keeping the price target at $7.50. Ed Arce’s rating is based on a combination ...

Bracknell, UK, 17 November 2023 – The National Institute for Health and Care Excellence (NICE) has issued its Final Draft Guidance (FDG) recommending empagliflozin (Jardiance ®) as an option for the ...

Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus ...